US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (256)
  • Diseases & Conditions (4053)
  • Drug Delivery (285)
  • Therapeutic Area (7289)
  • Vaccines (722)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition
7/16/2014 | published by: Kalorama Information
... with base year data for 2014, Clinical Nutrition Products: A Worldwide Perspective is a Kalorama Information report that focuses on three primary segments of essential medical nutrition: Infant Nutrition (Milk-based, Soy-based, Elemental, Follow-Up, Organic, Probiotic ...  |  read more...
USD 3,995
Cardiomyopathy Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Trichotillomania Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... relating to the clinical trials on Trichotillomania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Tropical Spastic Paraparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Upper Limb Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Vocal Cord Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Physician Views: US formulary management in diabetes – are endocrinologists impressed?
8/12/2014 | published by: FirstWord
... according to analysts and industry commentators – see Spotlight On: Pharma watch out! – US formulary exclusions expected to increase in 2015. Characterised by an increasing number of relatively undifferentiated products within each of the ...  |  read more...
USD 645
Psoriatic Arthritis Market Info: 2014 ™
8/7/2014 | published by: Drug Market Info
... affects up to 30% of people with psoriasis. This chronic arthritis increases pain sensitivity while causing long-term joint damage and crippling. However, recent research shows early diagnosis and treatment can prevent PsA from becoming a ...  |  read more...
USD 4,950
Psoriasis Market Info™: 2014
8/7/2014 | published by: Drug Market Info
... million Americans. The Psoriasis market is expected to grow significantly in the future, largely due to the chronic nature of the disease and high unmet patient needs. The uptake of biologics, new treatment combinations, and ...  |  read more...
USD 4,950
Medical and Scientific Research, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
... and ARM LIMITED. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research Global analysis is perfect for investors to: See the market leaders ...  |  read more...
USD 1,425
Medical and Scientific Research in Europe
8/12/2014 | published by: Plimsoll Publishing Ltd.
... NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO and CBMM EUROPE B.V.. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research European analysis is perfect ...  |  read more...
USD 1,200
Alliance Boots Plc in Consumer Health (Saudi Arabia)
8/8/2014 | published by: Euromonitor International
... chemists/pharmacists should help Alliance Boots to benefit from strong brand loyalty amongst women. The company is therefore expected to increase its footprint in Saudi Arabia, with the opening of new stores across the country, enabling ...  |  read more...
USD 150
Bayer Hispania SA in Consumer Health (Spain)
8/6/2014 | published by: Euromonitor International
... Hispania will seek new growth momentum in the categories in which it holds a leading position, by launching new formulations and packaging and delivery methods, as seen with its main brand Aspirina. Bayer Hispania is ...  |  read more...
USD 150
Bicentury SL in Consumer Health (Spain)
8/6/2014 | published by: Euromonitor International
... company continues to focus its activity on enlarging its portfolio of products, especially those to suppress appetite between meals. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken ...  |  read more...
USD 150
Novartis Farmaceutica SA in Consumer Health (Spain)
8/6/2014 | published by: Euromonitor International
... In this regard, Sandoz (its generics division) is expected to benefit over the forecast period. Recently the company signed a new deal with internet giant Google to develop “intelligent contact lenses” for diabetic patients. If ...  |  read more...
USD 150
Riyadh Pharma Medical & Cosmetic Products Co Ltd in Consumer Health (Saudi Arabia)
8/8/2014 | published by: Euromonitor International
... strengthen its position within healthcare. The company is expected to increase its partnerships with key international players through its licensing agreement activity to match consumers’ expectations in terms of product and brand offers of generics. ...  |  read more...
USD 150
Calming and Sleeping - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... impacted consumers’ health, resulting in insomnia and stress. These contributory factors thereby enabled calming and sleeping to see higher consumer demand in 2013, with current value growth of 15% in Saudi Arabia. Euromonitor International's Calming ...  |  read more...
USD 900
Calming and Sleeping - Spain
8/6/2014 | published by: Euromonitor International
... sales of these products, which are designed to contribute to wellbeing, at a time when sales of most OTC medicines were in decline. Euromonitor International's Calming and Sleeping in Spain report offers a comprehensive guide ...  |  read more...
USD 900
Cough, Cold and Allergy (Hay Fever) Remedies - Spain
8/6/2014 | published by: Euromonitor International
... change in prescription products that occurred in 2012, a number of drugs are now not dispensed by the Spanish health system, which led consumers to purchase these products in chemists/pharmacies. Euromonitor International's Cough, Cold and ...  |  read more...
USD 900
Digestive Remedies - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... widespread culture of eating out is chiefly driven by the rising consumption of junk food. This therefore led consumers to move towards self-medication thanks to the growing advertising of digestive remedies. As a result, digestive ...  |  read more...
USD 900
Digestive Remedies - Spain
8/6/2014 | published by: Euromonitor International
... the government in order to reduce the public deficit. As such, the number of medicines that passed from being reimbursed to being OTC continued to expand during 2013, which directly benefited digestive remedies. Euromonitor International's ...  |  read more...
USD 900
Herbal/Traditional Products - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... However, health-consciousness has started to gain ground amongst consumers and pharmacists. This therefore resulted in higher consumer demand for herbal/traditional products in 2013. As a result, herbal/traditional products registered value growth in current terms in ...  |  read more...
USD 900
NRT Smoking Cessation Aids - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... thanks to the fad of smoking shisha in Saudi Arabia. The government therefore started to introduce a smoking ban in 2011 in airports, and then in July 2012 in most public places and government offices. ...  |  read more...
USD 900
Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?
8/14/2014 | published by: FirstWord
... myeloma patients, thus greatly multiplying the drug's commercial potential. In the three quarters since the deal closed, investors have put up with relatively unremarkable sales growth for Kyprolis but have been getting antsy waiting for ...  |  read more...
USD 645
NRT Smoking Cessation Aids - Spain
8/6/2014 | published by: Euromonitor International
... interest in quitting smoking in 2013, which benefited sales of NRT smoking cessation aids in Spain, which grew by 1% to reach €24 million. Euromonitor International's NRT Smoking Cessation Aids in Spain report offers a ...  |  read more...
USD 900
< prev 1    3  4  5  6  7  8  9  10